Part 1/10:
Innovating Affordable Healthcare: How Vayu is Changing the Game
Every year, countless babies around the world lose their lives due to preventable causes, many of which stem from neonatal respiratory illnesses. One of the most effective interventions for saving these vulnerable infants is Continuous Positive Airway Pressure (CPAP), a device that provides oxygen therapy to premature babies struggling to breathe. While CPAP has been shown to improve survival rates by up to 66%, its high cost—often around $15,000—limits accessibility, especially in developing countries where healthcare resources are scarce.